{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:52:35Z","timestamp":1786981955175,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,2,2]],"date-time":"2008-02-02T00:00:00Z","timestamp":1201910400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Behav Health Serv Res"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s11414-007-9101-3","type":"journal-article","created":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T08:58:17Z","timestamp":1201856297000},"page":"215-225","source":"Crossref","is-referenced-by-count":17,"title":["Employment Outcomes in a Randomized Trial of Second-Generation Antipsychotics and Perphenazine in the Treatment of Individuals with Schizophrenia"],"prefix":"10.1007","volume":"35","author":[{"given":"Sandra G.","family":"Resnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Rosenheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Canive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"De Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Scott","family":"Stroup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard SE","family":"Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,2]]},"reference":[{"issue":"Suppl 11","key":"9101_CR1","first-page":"68","volume":"57","author":"JA Lieberman","year":"1996","unstructured":"Lieberman JA. Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis. Journal of Clinical Psychiatry. 1996;57(Suppl 11):68\u201371.","journal-title":"Journal of Clinical Psychiatry"},{"key":"9101_CR2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.schres.2004.05.009","volume":"75","author":"SG Resnick","year":"2005","unstructured":"Resnick SG, Fontana A, Lehman AF, et al. An empirical conceptualization of the recovery orientation. Schizophrenia Research. 2005;75:119\u2013128.","journal-title":"Schizophrenia Research"},{"key":"9101_CR3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2165\/00019053-200422110-00002","volume":"22","author":"M Percudani","year":"2004","unstructured":"Percudani M, Barbui C, Tansella M. Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia. Pharmacoeconomics. 2004;22:701\u2013718.","journal-title":"Pharmacoeconomics"},{"key":"9101_CR4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00019053-200624020-00003","volume":"24","author":"D Salkever","year":"2006","unstructured":"Salkever D, Slade E, Karakus M. Differential effects of atypical versus typical antipsychotic medication on earnings of schizophrenia patients: estimates from a prospective naturalistic study. Pharmacoeconomics. 2006;24:123\u2013139.","journal-title":"Pharmacoeconomics"},{"key":"9101_CR5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4088\/JCP.v62n0308","volume":"62","author":"AK Malla","year":"2001","unstructured":"Malla AK, Norman RMG, Scholten DJ, et al. A comparison of long-term outcome in first-episode schizophrenia following treatment with risperidone or a typical antipsychotic. Journal of Clinical Psychiatry. 2001;62:179\u2013184.","journal-title":"Journal of Clinical Psychiatry"},{"key":"9101_CR6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00004850-200015050-00001","volume":"15","author":"SH Hamilton","year":"2000","unstructured":"Hamilton SH, Edgell ET, Revicki DA. Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample. International Clinical Psychopharmacology. 2000;15:245\u2013255.","journal-title":"International Clinical Psychopharmacology"},{"key":"9101_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/appi.ps.55.1.59","volume":"55","author":"GR Bond","year":"2004","unstructured":"Bond GR, Kim H-W, Meyer P, et al. Response to vocational rehabilitation during treatment with first- or second-generation antipsychotics. Psychiatric Services. 2004;55:59\u201366.","journal-title":"Psychiatric Services"},{"key":"9101_CR8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4088\/JCP.v63n0204","volume":"63","author":"PS Meyer","year":"2002","unstructured":"Meyer PS, Bond GR, Tunis SL. Comparison between the effects of atypical and traditional antipsychotics on work status for clients in a psychiatric rehabilitation program. Journal of Clinical Psychiatry. 2002;63:108\u2013116.","journal-title":"Journal of Clinical Psychiatry"},{"key":"9101_CR9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0920-9964(99)00154-1","volume":"43","author":"L Vorunganti","year":"2000","unstructured":"Vorunganti L, Cortese L, Oyewumi L, et al. Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life. Schizophrenia Research. 2000;43:135\u2013145.","journal-title":"Schizophrenia Research"},{"key":"9101_CR10","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. The New England Journal of Medicine. 2005;353:1209\u20131223.","journal-title":"The New England Journal of Medicine"},{"key":"9101_CR11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1176\/appi.ajp.163.3.411","volume":"163","author":"R Rosenheck","year":"2006","unstructured":"Rosenheck R, Leslie D, Keefe R, et al. Barriers to employment for people with schizophrenia. American Journal of Psychiatry. 2006;163:411\u2013417.","journal-title":"American Journal of Psychiatry"},{"key":"9101_CR12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1176\/ajp.154.4.466","volume":"154","author":"GD Toffelson","year":"1997","unstructured":"Toffelson GD, Sanger TM. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine. American Journal of Psychiatry. 1997;154:466\u2013474.","journal-title":"American Journal of Psychiatry"},{"key":"9101_CR13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archpsyc.1983.01790040023003","volume":"40","author":"AF Lehman","year":"1983","unstructured":"Lehman AF. The well-being of chronic mental patients. Archives of General Psychiatry. 1983;40:369\u2013373.","journal-title":"Archives of General Psychiatry"},{"key":"9101_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.schbul.a006989","volume":"29","author":"MS Swartz","year":"2003","unstructured":"Swartz MS, Perkins DO, Stroup TS, et al. Assessing clinical and functional outcomes in the Clinical Antipsychotic Trial of Intervention Effectiveness (CATIE) Schizophrenia Trial. Schizophrenia Bulletin. 2003;29:33\u201343.","journal-title":"Schizophrenia Bulletin"},{"key":"9101_CR15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev.pu.14.050193.000355","volume":"14","author":"K Liang","year":"1993","unstructured":"Liang K, Zeger S. Regression analysis for correlated data. Annual Review of Public Health. 1993;14:43\u201368.","journal-title":"Annual Review of Public Health"},{"key":"9101_CR16","first-page":"39","volume":"6","author":"PW Lavori","year":"1992","unstructured":"Lavori PW. Clinical trials in psychiatry: should protocol deviation censor patient data? Neuropsychopharmacology. 1992;6:39\u201348.","journal-title":"Neuropsychopharmacology"},{"key":"9101_CR17","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1176\/ajp.2006.163.12.2080","volume":"163","author":"RA Rosenheck","year":"2006","unstructured":"Rosenheck RA, Leslie D, Sindelar J, et al. Cost-effectiveness of second generation antipsychotics and perphenazine in the treatment of chronic schizophrenia. American Journal of Psychiatry. 2006;163:2080\u20132089.","journal-title":"American Journal of Psychiatry"},{"key":"9101_CR18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","volume":"75","author":"YA Hochberg","year":"1988","unstructured":"Hochberg YA. A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988;75:800\u2013802.","journal-title":"Biometrika"},{"key":"9101_CR19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","volume":"163","author":"JP McEvoy","year":"2006","unstructured":"McEvoy JP, Lieberman JA, Stroup TS, et al. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. American Journal of Psychiatry. 2006;163:600\u2013610.","journal-title":"American Journal of Psychiatry"},{"key":"9101_CR20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1176\/ajp.2006.163.4.611","volume":"163","author":"TS Stroup","year":"2006","unstructured":"Stroup TS, Lieberman JA, McEvoy JP, et al. Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. American Journal of Psychiatry. 2006;163:611\u2013622.","journal-title":"American Journal of Psychiatry"},{"key":"9101_CR21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1037\/h0099582","volume":"XI","author":"WA Anthony","year":"1987","unstructured":"Anthony WA, Blanch A. Supported employment for persons who are psychiatrically disabled: An historical and conceptual perspective. Psychsocial Rehabilitation Journal. 1987;XI:5\u201323.","journal-title":"Psychsocial Rehabilitation Journal"},{"key":"9101_CR22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/oxfordjournals.schbul.a006874","volume":"27","author":"K Mueser","year":"2001","unstructured":"Mueser K, Salyers M, Mueser P. A prospective analysis of work in schizophrenia. Schizophrenia Bulletin. 2001;27:281\u2013296.","journal-title":"Schizophrenia Bulletin"},{"key":"9101_CR23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1586\/14737167.7.2.103","volume":"7","author":"RA Rosenheck","year":"2007","unstructured":"Rosenheck RA, Swartz M, McEvoy J, et al. Changing perspectives on second generation antipsychotics: reviewing the cost-effectiveness component of the CATIE trial. Expert Review of Pharmacoeconomics and Outcomes Research. 2007;7:103\u2013111.","journal-title":"Expert Review of Pharmacoeconomics and Outcomes Research"},{"key":"9101_CR24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1037\/0022-006X.64.2.391","volume":"2","author":"RE Drake","year":"1996","unstructured":"Drake RE, McHugo GJ, Becker DR, et al. The New Hampshire study of supported employment for people with severe mental illness. Journal of Consulting and Clinical Psychology. 1996;2:391\u2013399.","journal-title":"Journal of Consulting and Clinical Psychology"}],"container-title":["The Journal of Behavioral Health Services & Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11414-007-9101-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11414-007-9101-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11414-007-9101-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T10:45:27Z","timestamp":1559385927000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11414-007-9101-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["9101"],"URL":"https:\/\/doi.org\/10.1007\/s11414-007-9101-3","relation":{},"ISSN":["1094-3412","1556-3308"],"issn-type":[{"value":"1094-3412","type":"print"},{"value":"1556-3308","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,2]]}}}